Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04360525
Recruitment Status : Completed
First Posted : April 24, 2020
Last Update Posted : April 24, 2020
Sponsor:
Collaborator:
Inonu University
Information provided by (Responsible Party):
Ufuk Uylas, Dr. Ersin Arslan Education and Training Hospital

Brief Summary:
Sigmoid volvulus is frequently seen in male patients over 60 years old. In the sigmoid volvulus <60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in <60 age groups, it is more likely to be another underlying organic pathology.

Condition or disease Intervention/treatment
Pathology Other: Reasons

Detailed Description:
Sigmoid volvulus is frequently seen in male patients over 60 years old. Here, the investigators aimed to investigate the causes of sigmoid volvulus developing in patients under 60 years of age. Patients diagnosed with sigmoid volvulus between 2009 and 2018 were retrospectively screened. The patients were divided into two as under 60 years old and above. The co-morbidity, mortality, morbidity, complications, age and gender data of the patients were analyzed. In the sigmoid volvulus <60 age groups, the male/female ratio is close to each other. If sigmoid volvulus develops in <60 age groups, it is more likely to be another underlying organic pathology.

Layout table for study information
Study Type : Observational
Actual Enrollment : 134 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Different Clinicopathological Features of Non-Elderly Sigmoid Volvulus Patients
Actual Study Start Date : January 1, 2020
Actual Primary Completion Date : April 1, 2020
Actual Study Completion Date : April 18, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Elderly patients
Elderly patients (60≤ age) with sigmoid volvulus
Other: Reasons
Causes of sigmoid volvulus

Young patients
Young patients (<60 age) with sigmoid volvulus
Other: Reasons
Causes of sigmoid volvulus




Primary Outcome Measures :
  1. Mortality [ Time Frame: up to three months ]
    Elderly and young patients mortality

  2. Morbidity [ Time Frame: up to three months ]
    Elderly and young patients morbidity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who were treated for the sigmoid volvulus between 2009 and 2018 at Inonu University General Surgery Clinic.
Criteria

Inclusion Criteria:

  • Sigmoid volvulus patients under the age of 60
  • Sigmoid volvulus patients at the age of ≥60

Exclusion Criteria:

  • Lack of data

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04360525


Locations
Layout table for location information
Turkey
Dr. Ersin Arslan Training and Resource Hospital
Gaziantep, Turkey
Sponsors and Collaborators
Dr. Ersin Arslan Education and Training Hospital
Inonu University
Investigators
Layout table for investigator information
Principal Investigator: ufuk uylas, Specialist Dr. Ersin Arslan Training and Resource Hospital
Layout table for additonal information
Responsible Party: Ufuk Uylas, Specialist, Dr. Ersin Arslan Education and Training Hospital
ClinicalTrials.gov Identifier: NCT04360525    
Other Study ID Numbers: 18042020
First Posted: April 24, 2020    Key Record Dates
Last Update Posted: April 24, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ufuk Uylas, Dr. Ersin Arslan Education and Training Hospital:
dolichocolon
volvulus
sigmoid
Parkinson
mental retardation
Hirschsprung's disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Intestinal Volvulus
Intestinal Obstruction
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Torsion Abnormality
Pathological Conditions, Anatomical